Bone Tumors
Surgeons push barriers with 3D printing for bone tumors
Despite the long-established prevalence of 3D printing in orthopedic oncology, some orthopedic surgeons said recent technological improvements and novel applications of the tool may help change the way cancerous tumors are treated.
Do surgeons need to utilize 3D printing in orthopedic oncology?
When applying new technology to any medical intervention, we should begin with the end in mind and ask what problem are we trying to solve and could this new technology cause more harm than current solutions.
Ghert receives Kappa Delta Ann Doner Vaughn Award at AAOS Annual Meeting
Michelle Ghert, MD, FRCSC, received the Kappa Delta Ann Doner Vaughn Award on behalf of the Prophylactic Antibiotic Regimens in Tumor Surgery investigators at the American Academy of Orthopaedic Surgeons Annual Meeting.
Chlorhexidine gluconate solution yielded positive results for irrigation of bone tumors
According to published results, use of a 0.05% chlorhexidine gluconate solution may serve as a chemical adjuvant to intralesional curettage for patients with chondrosarcomas and giant cell tumors.
Stryker receives FDA 510(k) clearance for bone tumor ablation system
Stryker has announced FDA 510(k) clearance for its OptaBlate bone tumor ablation system for patients with metastatic cancer, according to a press release.
Surgical resection of metacarpal bone tumors may yield satisfactory outcomes
Published results showed patients with malignant and aggressive benign tumors of the metacarpal bones may experience satisfactory functional and oncologic outcomes after surgical resection.